Purple Biotech Ltd. (PPBT)
4.125
+0.21
(+5.50%)
USD |
NASDAQ |
May 08, 16:00
3.95
-0.18
(-4.24%)
After-Hours: 20:00
Purple Biotech Shareholders Equity (Quarterly) : 9.714M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 8.228B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 43.63M |
| Sol-Gel Technologies Ltd. | 22.81M |
| InterCure Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.57M |
| Total Liabilities (Quarterly) | 7.913M |
| Debt to Equity Ratio | 0.0251 |
| Current Ratio | 1.272 |
| Net Debt Paydown Yield | -0.07% |